Elekta ABMEX:EKTAB N 79 3-Year EPS without NRI Growth Rate is -0.50% as of Apr. 2026. GuruFocus rates MEX:EKTAB N with a GF Score™ of 79/100 and a GF Value™ of MXN158.57. The stock has 6 warning signs investors should review. Among 667 Medical Devices & Instruments companies, Elekta AB ranks worse than 62.52% on this metric.
During the past 12 months, Elekta AB's average EPS without NRI Growth Rate was -21.10% per year.
During the past 3 years, the average EPS without NRI Growth Rate was -0.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -3.00% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 4.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Elekta AB was 35.00% per year. The lowest was -24.30% per year. And the median was 11.90% per year.
Elekta AB (MEX:EKTAB N) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Elekta AB 3-Year EPS without NRI Growth Rate Related Terms
MEX:EKTAB N vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, Elekta AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Elekta AB's 3-Year EPS without NRI Growth Rate falls into.
Elekta AB 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -0.50% mean?
Elekta AB (MEX:EKTAB N) has a 3-Year EPS without NRI Growth Rate of -0.50% as of Apr. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Elekta AB and its competitors. According to the industry distribution chart, Elekta AB ranks #417 out of 667 companies in the Medical Devices & Instruments industry, placing it in the top 62.5%.
Is Elekta AB's 3-Year EPS without NRI Growth Rate too high?
Elekta AB's current 3-Year EPS without NRI Growth Rate is -0.50%. Based on the distribution chart, Elekta AB ranks #417 out of 667 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #417 out of 667 companies for 3-Year EPS without NRI Growth Rate. This places Elekta AB in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.00, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current 3-Year EPS without NRI Growth Rate is -0.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current 3-Year EPS without NRI Growth Rate of -0.50%. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is -0.50%. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current 3-Year EPS without NRI Growth Rate is -0.50% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.
Key valuation signals for MEX:EKTAB N:
3-Year EPS without NRI Growth Rate: -0.50%
GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score
Get the complete analysis for MEX:EKTAB N
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EKTAB N has been successfully added to your 